Recombinant Activated Factor VII clinical trials

An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

This study looks at how well current treatments for severe Von Willebrand Disease (Type 3) work. It observes people already on their usual treatment to see how they manage their condition and how it affects their daily lives.